Abstract
Background:National British Society of Rheumatology guidelines for monitoring non-biologic disease-modifying anti-rheumatic drugs (DMARDs) suggest reducing the frequency of blood monitoring for patients on stable doses of methotrexate to 12 week...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
